vs
ASSOCIATED BANC-CORP（ASB）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
ASSOCIATED BANC-CORP的季度营收约是IDEAYA Biosciences, Inc.的1.8倍（$383.0M vs $207.8M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 31.2%，领先26.1%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
ASB vs IDYA — 直观对比
营收规模更大
ASB
是对方的1.8倍
$207.8M
净利率更高
IDYA
高出26.1%
31.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $207.8M |
| 净利润 | $119.6M | $119.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 52.2% |
| 净利率 | 31.2% | 57.4% |
| 营收同比 | — | — |
| 净利润同比 | 566.6% | 330.1% |
| 每股收益（稀释后） | $0.70 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBIDYA
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | — | ||
| Q3 25 | $305.2M | $207.8M | ||
| Q2 25 | $300.0M | — | ||
| Q1 25 | $285.9M | — | ||
| Q4 24 | $270.3M | — | ||
| Q3 24 | $329.7M | $0 | ||
| Q2 24 | $321.8M | $0 |
净利润ASBIDYA
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | — | ||
| Q3 25 | $124.7M | $119.2M | ||
| Q2 25 | $111.2M | — | ||
| Q1 25 | $101.7M | — | ||
| Q4 24 | $-161.6M | — | ||
| Q3 24 | $88.0M | $-51.8M | ||
| Q2 24 | $115.6M | $-52.8M |
营业利润率ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | — | ||
| Q3 25 | 50.5% | 52.2% | ||
| Q2 25 | 46.5% | — | ||
| Q1 25 | 42.3% | — | ||
| Q4 24 | -65.8% | — | ||
| Q3 24 | 32.8% | — | ||
| Q2 24 | 32.0% | — |
净利率ASBIDYA
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | — | ||
| Q3 25 | 40.9% | 57.4% | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | -59.8% | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 35.9% | — |
每股收益（稀释后）ASBIDYA
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | — | ||
| Q3 25 | $0.73 | $1.33 | ||
| Q2 25 | $0.65 | — | ||
| Q1 25 | $0.59 | — | ||
| Q4 24 | $-1.10 | — | ||
| Q3 24 | $0.56 | $-0.60 | ||
| Q2 24 | $0.74 | $-0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $786.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.0B | $1.1B |
| 总资产 | $45.6B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M |
总债务ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $594.1M | — | ||
| Q2 25 | $593.5M | — | ||
| Q1 25 | $591.4M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $844.3M | — | ||
| Q2 24 | $536.1M | — |
股东权益ASBIDYA
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | — | ||
| Q3 25 | $4.9B | $1.1B | ||
| Q2 25 | $4.8B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.6B | — | ||
| Q3 24 | $4.4B | $1.2B | ||
| Q2 24 | $4.2B | $931.7M |
总资产ASBIDYA
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | — | ||
| Q3 25 | $44.5B | $1.2B | ||
| Q2 25 | $44.0B | — | ||
| Q1 25 | $43.3B | — | ||
| Q4 24 | $43.0B | — | ||
| Q3 24 | $42.2B | $1.2B | ||
| Q2 24 | $41.6B | $973.7M |
负债/权益比ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $142.2M |
| 自由现金流经营现金流 - 资本支出 | — | $142.2M |
| 自由现金流率自由现金流/营收 | — | 68.4% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.19× |
| 过去12个月自由现金流最近4个季度 | — | $13.5M |
8季度趋势，按日历期对齐
经营现金流ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | — | ||
| Q3 25 | $158.0M | $142.2M | ||
| Q2 25 | $141.5M | — | ||
| Q1 25 | $98.2M | — | ||
| Q4 24 | $207.1M | — | ||
| Q3 24 | $105.1M | $-49.2M | ||
| Q2 24 | $113.5M | $-32.9M |
自由现金流ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
自由现金流率ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率ASBIDYA
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | — | ||
| Q3 25 | 1.27× | 1.19× | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 0.97× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 0.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
IDYA
暂无分部数据
